UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000010681
Receipt No. R000012488
Scientific Title Multicenter randomized phase II study of cisplatin+pemetrexed+bevacizmab followed by maintenance pemetrexied with or without bevacizmab in patients chemoterapy-naive advanced non-squamous non-small cell lung cancer with wild type EGFR(TORG1321)
Date of disclosure of the study information 2013/05/17
Last modified on 2019/04/24 09:27:19

No. Disposal Last modified on Item of update
1 Insert 2013/05/09 14:57:39
2 Update 2013/11/11 12:52:49 Email
Last name of contact person
Last name of contact person
Address
Email
3 Update 2014/06/09 10:23:37 Organization
Organization
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
4 Update 2014/07/18 10:39:25 Email
5 Update 2014/11/11 13:12:37 Name of person sending information
Name of person sending information
Email1
6 Update 2015/11/11 14:38:31 Randomization unit
Control
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
7 Update 2016/05/09 09:08:06 Name of primary sponsor
Organization
Organization
Category of Funding Organization
8 Update 2019/04/24 09:27:19 Recruitment status
Date of IRB
Last follow-up date


Contact us.